<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/'><id>tag:blogger.com,1999:blog-5199522738412628687.post599259935458382914..comments</id><updated>2009-06-17T12:10:38.680-05:00</updated><category term='mobile'/><category term='med/legal/reg challenges'/><category term='Quality Health'/><category term='measurement'/><category term='warning letters'/><category term='Pharma humor'/><category term='privacy'/><category term='sanofi-aventis'/><category term='analytics'/><category term='UCB'/><category term='epharma'/><category term='FDA'/><category term='Web design'/><category term='PatientsLikeMe'/><category term='pharma marketing'/><category term='ADHD'/><category term='PhRMA Guidelines'/><category term='online media'/><category term='Everyday Health'/><category term='web 3.0'/><category term='DTC'/><category term='emails'/><category term='Med Ad News'/><category term='customer service'/><category term='celebrity spokespeople'/><category term='Prospectiv'/><category term='government'/><category term='Abbott'/><category term='MySpace'/><category term='agency models'/><category term='big agencies'/><category term='Tweetpharm'/><category term='GoInsulin'/><category term='integration'/><category term='ALS'/><category term='FTC'/><category term='Sermo'/><category term='persistence'/><category term='patient-centricity'/><category term='innovation'/><category term='Crossix'/><category term='isi'/><category term='ePharma Summit'/><category term='WebMD'/><category term='DailyStrength'/><category term='conferences'/><category term='segmentation'/><category term='Sidewiki'/><category term='technology'/><category term='Twitter'/><category term='Health Central'/><category term='AdRx'/><category term='brainstorms'/><category term='EyeForPharma'/><category term='SNL skit'/><category term='IT'/><category term='DTC humor'/><category term='ebook'/><category term='creativity'/><category term='vintage pharma'/><category term='Pew'/><category term='MOA'/><category term='SEM'/><category term='social networking'/><category term='Blackberry'/><category term='buzzword bingo'/><category term='planning'/><category term='Wall Street Journal'/><category term='retention'/><category term='Rozerem'/><category term='adherence'/><category term='sharesendsave'/><category term='search marketing'/><category term='learning'/><category term='Facebook'/><category term='Manhattan Research'/><category term='Yahoo'/><category term='hype'/><category term='Genentech'/><category term='Unbranded site strategy'/><category term='ROI'/><category term='coupons'/><category term='Manny Awards'/><category term='social sharing'/><category term='videos'/><category term='unbranded Web sites'/><category term='2010'/><category term='eCRM'/><category term='YouTube'/><category term='Shire'/><category term='FirstWord'/><category term='Google'/><category term='AdAge'/><category term='being a patient'/><category term='user experience design'/><category term='Economy'/><category term='Bing'/><category term='health information seekers'/><category term='digital agency'/><category term='awards'/><category term='compliance'/><category term='public relations'/><category term='independence'/><category term='social media'/><category term='BrandWeek'/><category term='Digital Pharma'/><category term='back pain'/><title type='text'>Comments on ePharma Rx: The Twitter Craze in the Context of ePharma</title><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://blog.intouchsol.com/feeds/599259935458382914/comments/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5199522738412628687/599259935458382914/comments/default'/><link rel='alternate' type='text/html' href='http://blog.intouchsol.com/2009/06/twitter-craze-in-context-of-epharma.html'/><author><name>Wendy W. Blackburn</name><uri>http://www.blogger.com/profile/01712567520098554819</uri><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='24' height='32' src='http://3.bp.blogspot.com/_N3mwtdW7vDY/TEXvfAHzL1I/AAAAAAAAALs/futJRotbPjY/S220/Wendy_new_July2010_crop.jpg'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>2</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-5199522738412628687.post-5778388664798215848</id><published>2009-06-17T11:42:04.671-05:00</published><updated>2009-06-17T11:42:04.671-05:00</updated><title type='text'>Great article, thank you.  I really like what you ...</title><content type='html'>Great article, thank you.  I really like what you said about using Twitter to improve brand recognition and reputation.  &lt;br /&gt;&lt;br /&gt;Thanks for the info!</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5199522738412628687/599259935458382914/comments/default/5778388664798215848'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5199522738412628687/599259935458382914/comments/default/5778388664798215848'/><link rel='alternate' type='text/html' href='http://blog.intouchsol.com/2009/06/twitter-craze-in-context-of-epharma.html?showComment=1245256924671#c5778388664798215848' title=''/><author><name>Nicole Rivera</name><uri>http://www.smihealthmedia.com</uri><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img1.blogblog.com/img/blank.gif'/></author><thr:in-reply-to xmlns:thr='http://purl.org/syndication/thread/1.0' href='http://blog.intouchsol.com/2009/06/twitter-craze-in-context-of-epharma.html' ref='tag:blogger.com,1999:blog-5199522738412628687.post-599259935458382914' source='http://www.blogger.com/feeds/5199522738412628687/posts/default/599259935458382914' type='text/html'/><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='blogger.itemClass' value='pid-293979015'/></entry><entry><id>tag:blogger.com,1999:blog-5199522738412628687.post-8760160074890889166</id><published>2009-06-08T15:28:11.256-05:00</published><updated>2009-06-08T15:28:11.256-05:00</updated><title type='text'>Nice overview of the phenomenon, especially &amp;quot;...</title><content type='html'>Nice overview of the phenomenon, especially &amp;quot;Twitter 101&amp;quot; and your 4 points about how pharma might use Twitter to its advantage.  Brand reputation management is vital as you point out with the Domino&amp;#39;s example, and as McNeil learned with &amp;quot;Motrin Moms.&amp;quot;  If companies do nothing more than simply monitor mentions they will go a long way to not only preventing PR disasters, but setting themselves up as potential heroes.</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5199522738412628687/599259935458382914/comments/default/8760160074890889166'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5199522738412628687/599259935458382914/comments/default/8760160074890889166'/><link rel='alternate' type='text/html' href='http://blog.intouchsol.com/2009/06/twitter-craze-in-context-of-epharma.html?showComment=1244492891256#c8760160074890889166' title=''/><author><name>Mark Hollander</name><uri>http://group8020.com/blog/</uri><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img1.blogblog.com/img/blank.gif'/></author><thr:in-reply-to xmlns:thr='http://purl.org/syndication/thread/1.0' href='http://blog.intouchsol.com/2009/06/twitter-craze-in-context-of-epharma.html' ref='tag:blogger.com,1999:blog-5199522738412628687.post-599259935458382914' source='http://www.blogger.com/feeds/5199522738412628687/posts/default/599259935458382914' type='text/html'/><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='blogger.itemClass' value='pid-1100589009'/></entry></feed>
